164 related articles for article (PubMed ID: 81851)
21. Human cytotoxic response in vitro to trinitrophenyl-modified autologous cells. II. Diversity of self determinants recognized in association with TNP.
Shaw S; Shearer GM
J Immunol; 1978 Jul; 121(1):290-9. PubMed ID: 78944
[No Abstract] [Full Text] [Related]
22. Cellular and genetic control of antibody responses. VI. Expression of Ir gene function by H-2a accessory cells, but not H-2a T or B cells in responses to TNP-(T,G)-A--L.
Hodes RJ; Hathcock KS; Singer A
J Immunol; 1979 Dec; 123(6):2823-9. PubMed ID: 115922
[No Abstract] [Full Text] [Related]
23. Ontogeny of anti-self-trinitrophenyl cytotoxic T-cell responses.
Schmitt-Verhulst AM; Cooley MA; Buferne M
Thymus; 1981 Aug; 3(2):77-85. PubMed ID: 6974916
[TBL] [Abstract][Full Text] [Related]
24. Production and characterization of T-cell clones specific for trinitrophenyl (TNP)-modified syngeneic spleen cells (TNP-self).
Arora PK; Hanna EE
Indian J Exp Biol; 1989 Oct; 27(10):843-8. PubMed ID: 2483952
[TBL] [Abstract][Full Text] [Related]
25. TNP-specific Lyt-2+ cytolytic T cell clones preferentially respond to TNP-conjugated epidermal cells.
Shimada S; Katz SI
J Immunol; 1985 Sep; 135(3):1558-63. PubMed ID: 3874901
[TBL] [Abstract][Full Text] [Related]
26. In vitro responses of CBA/N mice: spleen cells of mice with an X-linked defect that precludes immune responses to several thymus-independent antigens can respond to TNP-lipopolysaccharide.
Mosier DE; Scher I; Paul WE
J Immunol; 1976 Oct; 117(4):1363-9. PubMed ID: 789772
[TBL] [Abstract][Full Text] [Related]
27. Human cytotoxic response in vitro to trinitrophenyl-modified autologous cells. I. T cell recognition of TNP in association with widely shared antigens.
Shaw S; Nelson DL; Shearer GM
J Immunol; 1978 Jul; 121(1):281-9. PubMed ID: 78943
[No Abstract] [Full Text] [Related]
28. Minimum peptide sequences necessary for priming and triggering of humoral and cell-mediated immune responses in mice: use of synthetic peptide antigens of defined structure.
Singh B; Lee KC; Fraga E; Wilkinson A; Wong M; Barton MA
J Immunol; 1980 Mar; 124(3):1336-43. PubMed ID: 6153678
[No Abstract] [Full Text] [Related]
29. Inhibition of killer-target cell interaction by monoclonal anti-H-2 antibodies.
Lindahl KF; Lemke H
Eur J Immunol; 1979 Jul; 9(7):526-36. PubMed ID: 91521
[No Abstract] [Full Text] [Related]
30. The secondary cytotoxic response to trinitrophenyl (TNP) modified syngeneic lymphocytes: effectors generated in vitro differ from those generated in vivo.
Tagart V
Scand J Immunol; 1978; 8(2):91-7. PubMed ID: 705261
[TBL] [Abstract][Full Text] [Related]
31. H-2 homology requirements for secondary cell-mediated lympholysis and miced lymphocyte reactions to TNP-modified syngeneic lymphocytes.
Schmitt-Verhulst AM; Garbarino CA; Shearer GM
J Immunol; 1977 Apr; 118(4):1420-7. PubMed ID: 66294
[TBL] [Abstract][Full Text] [Related]
32. Cell types required for H-2-restricted cytotoxic responses generated by trinitrobenzene sulfonate-modified syngeneic cells or trinitrophenyl-conjugated proteins.
Pettinelli CB; Schmitt-Verhulst AM; Shearer GM
J Immunol; 1979 Mar; 122(3):847-54. PubMed ID: 87418
[TBL] [Abstract][Full Text] [Related]
33. Limitations of recognition of modified-self by alloantigen-activated cytotoxic T lymphocytes.
Ballas ZK
J Immunol; 1981 Oct; 127(4):1589-91. PubMed ID: 6168697
[TBL] [Abstract][Full Text] [Related]
34. The induction of hapten-specific immunologic tolerance and immunity in B lymphocytes. III. In vitro evaluation of TNP-specific tolerance and evidence for B cell deletion.
Fidler JM
J Immunol; 1978 Jul; 121(1):245-54. PubMed ID: 307573
[No Abstract] [Full Text] [Related]
35. Regulation of thymus-independent responses: unresponsiveness to a second challenge of TNP-Ficoll is mediated by hapten-specific antibodies.
Brodeur PH; Wortis HH
J Immunol; 1980 Oct; 125(4):1499-505. PubMed ID: 6967907
[TBL] [Abstract][Full Text] [Related]
36. Studies on in-vivo priming of the trinitrophenyl-reactive cytotoxic effector-system. III. Are helper T cells involved in the in-vitro generation of cross-reactive as well as restricted cytotoxic responses?
Fujiwara H; Levy RB; Shearer GM
Immunobiology; 1982 Feb; 160(5):472-8. PubMed ID: 6978282
[TBL] [Abstract][Full Text] [Related]
37. Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.
Fujiwara H; Moriyama Y; Suda T; Tsuchida T; Shearer GM; Hamaoka T
J Immunol; 1984 Mar; 132(3):1571-7. PubMed ID: 6198397
[TBL] [Abstract][Full Text] [Related]
38. The murine B cell response to TNP-polyacrylamide beads: the relationship between the epitope density of the antigen and the requirements for T cell help and surface IgD.
Puré E; Vitetta ES
J Immunol; 1980 Jul; 125(1):420-7. PubMed ID: 6155404
[TBL] [Abstract][Full Text] [Related]
39. Limiting dilution analysis of induced unresponsiveness to trinitrophenyl: increased suppression of cytotoxic T precursor cells at unchanged frequencies.
Cooper JM; Eichmann K
J Mol Cell Immunol; 1985; 2(2):83-94. PubMed ID: 3880510
[TBL] [Abstract][Full Text] [Related]
40. Genetic control of antibody responses to TNP-nuclease in vitro.
Nadler PI; Miller GP; Sachs DH; Hodes RJ
J Immunol; 1981 May; 126(5):1706-12. PubMed ID: 6783697
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
